FinTrust Capital Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

FinTrust Capital Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-90	Closed	-$4	–	1194
2020 Q3	$4	Buy	+90	New	+$3.76K	﹤0.01%	1006
2019 Q2	–	Sell	-5,233	Closed	-$328K	–	1339
2019 Q1	$328K	Buy	5,233 +102	+2%	+$7.01K	0.14%	142
2018 Q4	$306K	Buy	+5,131	New	+$308K	0.15%	132

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

FinTrust Capital Advisors's BEAT Position: Q4 2020 in Review

FinTrust Capital Advisors sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 90 shares — an estimated $4 sold.

FinTrust Capital Advisors first reported a position in BEAT in Q4 2018 and held it in 3 quarters. The position peaked at $328K in Q1 2019. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

FinTrust Capital Advisors reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
FinTrust Capital Advisors sold 90 BioTelemetry, Inc. shares in Q4 2020, an estimated $4.
FinTrust Capital Advisors first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 3 quarters.
FinTrust Capital Advisors's BioTelemetry, Inc. position peaked at $328K in Q1 2019.
238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on FinTrust Capital Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.